Literature DB >> 24481673

Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing.

Gregory Kellogg1, Leah Slattery, Louanne Hudgins, Kelly Ormond.   

Abstract

Noninvasive prenatal testing (NIPT) allows for highly sensitive detection of Down syndrome early in pregnancy with no risk of miscarriage, therefore potentially increasing the number of pregnancies identified with Down syndrome. This study assesses how mothers of children with Down syndrome perceive NIPT, especially the impact they think it will have on their families and other families with children who have Down syndrome. Seventy-three self-reported mothers of children with Down syndrome responded to an anonymous online survey emailed to, and posted on, message boards of various Down syndrome support groups and networks. Data analysis included chi-square tests and thematic analysis. Fifty-nine percent of respondents indicated they would use NIPT in the future; respondents who had not used prenatal testing in the past were significantly less likely to report interest in using NIPT in the future than those who had prenatal testing previously (p < .001). Many respondents felt NIPT could lead to increased terminations (88 %), increased social stigma (57 %), and decreased availability of services for individuals with Down syndrome (64 %). However, only 16 % believed availability of new noninvasive tests would be the most important factor in determining the number of pregnancies with Down syndrome terminated in the future. Additionally, 48 % believed health care providers give biased or incorrect information about Down syndrome at the time of diagnosis, and 24 % felt this incorrect information leads to terminations of pregnancies affected with Down syndrome. Results suggest although mothers of children with Down syndrome believe new noninvasive testing will lead to an increase in termination of pregnancies with Down syndrome, they do not think it is the MOST important factor. They also highlight the need to provide a diagnosis of Down syndrome in a balanced and objective manner.

Entities:  

Mesh:

Year:  2014        PMID: 24481673      PMCID: PMC4119092          DOI: 10.1007/s10897-014-9694-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  28 in total

1.  Presence of fetal DNA in maternal plasma and serum.

Authors:  Y M Lo; N Corbetta; P F Chamberlain; V Rai; I L Sargent; C W Redman; J S Wainscoat
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  With new prenatal testing, will babies with Down syndrome slowly disappear?

Authors:  Brian G Skotko
Journal:  Arch Dis Child       Date:  2009-06-15       Impact factor: 3.791

3.  "Testing times, challenging choices": an Australian study of prenatal genetic counseling.

Authors:  Jan M Hodgson; Lynn H Gillam; Margaret A Sahhar; Sylvia A Metcalfe
Journal:  J Genet Couns       Date:  2009-10-02       Impact factor: 2.537

4.  Non-invasive prenatal testing: ethical issues explored.

Authors:  Antina de Jong; Wybo J Dondorp; Christine E M de Die-Smulders; Suzanne G M Frints; Guido M W R de Wert
Journal:  Eur J Hum Genet       Date:  2009-12-02       Impact factor: 4.246

5.  Get ready for the flood of fetal gene screening.

Authors:  Henry T Greely
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

6.  The role of genetic counseling in the elective termination of pregnancies involving fetuses with disabilities.

Authors:  Christy D Roberts; Laura D Stough; Linda H Parrish
Journal:  J Spec Educ       Date:  2002

7.  The decision to continue a pregnancy affected by Down syndrome: timing of decision and satisfaction with receiving a prenatal diagnosis.

Authors:  Emily Hurford; Anne Hawkins; Louanne Hudgins; Joanne Taylor
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

8.  Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.

Authors:  Naomi Nakata; Yuemei Wang; Sucheta Bhatt
Journal:  Prenat Diagn       Date:  2010-03       Impact factor: 3.050

9.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.

Authors:  H Christina Fan; Yair J Blumenfeld; Usha Chitkara; Louanne Hudgins; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-06       Impact factor: 11.205

10.  Which neurodevelopmental disorders get researched and why?

Authors:  Dorothy V M Bishop
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more
  21 in total

1.  "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening.

Authors:  Rosemary J Steinbach; Megan Allyse; Marsha Michie; Emily Y Liu; Mildred K Cho
Journal:  Am J Med Genet A       Date:  2015-11-14       Impact factor: 2.802

2.  Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis.

Authors:  Meredith Vanstone; Alexandra Cernat; Umair Majid; Forum Trivedi; Chanté De Freitas
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

3.  Old Questions, New Paradigms: Ethical, Legal, and Social Complications of Noninvasive Prenatal Testing.

Authors:  Marsha Michie; Megan Allyse
Journal:  AJOB Empir Bioeth       Date:  2015-01-01

4.  Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.

Authors:  Elizabeth Alexander; Susan Kelly; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2014-10-15       Impact factor: 2.537

5.  Women's Understanding and Attitudes towards Down Syndrome and Other Genetic Conditions in the Context of Prenatal Screening.

Authors:  Sarah Long; Peter O'Leary; Roanna Lobo; Jan E Dickinson
Journal:  J Genet Couns       Date:  2017-10-24       Impact factor: 2.537

6.  Attitudes of Filipino parents of children with Down syndrome on noninvasive prenatal testing.

Authors:  Leniza G de Castro-Hamoy; Ma-Am Joy R Tumulak; Maria Stephanie Fay S Cagayan; Peter A Sy; Nona Rachel C Mira; Mercy Y Laurino
Journal:  J Community Genet       Date:  2022-06-02

7.  Is preparation a good reason for prenatal genetic testing? Ethical and critical questions.

Authors:  Marsha Michie
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.344

8.  Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

Review 9.  Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond.

Authors:  Megan Allyse; Subhashini Chandrasekharan
Journal:  Genet Med       Date:  2015-03-19       Impact factor: 8.822

10.  Informed decision-making about prenatal cfDNA screening: An assessment of written materials.

Authors:  Marsha Michie; Stephanie A Kraft; Mollie A Minear; Roberta R Ryan; Megan A Allyse
Journal:  Ethics Med Public Health       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.